Cancer Patients With Prediabetes or Diabetes Have Higher Risk of MACE After Anthracyclines
Cancer patients with prediabetes or diabetes have an increased risk of MACE when they receive anthracyclines, data suggest. Cancer patients with prediabetes or diabetes have an increased risk of MACE when they receive anthracyclines, data suggest.
Source: cancertherapyadvisor.com